IL1A and cryopyrin-associated periodic syndrome: Third, the established and often dramatic beneficial effect of IL-1 blocking therapies in CAPS contrasts dramatically with difficulty showing benefit of IL-1 inhibition in sepsis (see Step 2c above) (Kuemmerle-Deschner, 2015; Welzel and Kuemmerle-Deschner, 2021).